Friday, 20 October 2017

Partner 11: University of Edinburgh - Division of Pathway Biology (DPM) (UEDIN)

The University of Edinburgh (www.ed.ac.uk) is one of the largest and most successful universities in the UK, with an international reputation as a centre of academic excellence, it is the leading research University in Scotland and is amongst the top ten in the United Kingdom. The University has been very successful in participating in European Framework Programmes, FP6, total award value of €74M and currently in the FP7 the University participates in some 267 projects with an award value of €141M. The College of Medicine and Veterinary Medicine has a long held international reputation for excellence in medical and veterinary medical research. The Division of Pathway Medicine (DPM: www.ed.ac.uk/pathway-medicine) is a centre for world-class post-genomic research, located within the University of Edinburgh Medical School. Our work integrates genomic science and systems biology with medicine and physical sciences, for understanding and innovating host- directed diagnosis and treatment of acquired diseases. Relevant to this project DPM has innovation in modelling immune metabolic pathways in infection and immunity. This includes identification of molecular-network biomarker of host response to bacterial infection in neonates The research activities of the DPM has led to formation of three spinout companies and several licensing agreements with industry.

Copyright © NeoVanc | All rights reserved. Read the disclaimer.
This project has received funding from the European Union’s Seventh Framework Programme for research, technological development and demonstration under grant agreement no: 602041
Call: FP7-HEALTH-2013-INNOVATION-1
Privacy policy | Cookie policy

E-mail: website@neovanc.org